A Three-in-One Strategy: Injectable Biomimetic Porous Hydrogels for Accelerating Bone Regeneration via Shape-Adaptable Scaffolds, Controllable Magnesium Ion Release, and Enhanced Osteogenic Differentiation
- 30 September 2021
- journal article
- research article
- Published by American Chemical Society (ACS) in Biomacromolecules
- Vol. 22 (11) , 4552-4568
Abstract
The repair of bone defects with irregular shapes, particularly in a minimally invasive manner, remains a major challenge. For synthetic bone grafts, injectable hydrogels are superior to conventional scaffolds because they can adapt satisfactorily to the defect margins and can be injected into deeper areas of injury via a minimally invasive procedure. Based on the poly(lactide-co-glycolide)(PLGA)/1-methyl-2-pyrrolidinone solution reported in our previous study, we successfully synthesized injectable MgO/MgCO3@PLGA (PMM) hydrogels, namely, injectable biomimetic porous hydrogels (IBPHs), to accelerate bone regeneration. In addition to exhibiting excellent injectability, PMM hydrogels could transform into porous scaffolds in situ through a liquid-to-solid phase transition and completely fill irregular bone defects via their superb shape adaptability. Moreover, sustainable and steady release of Mg2+ was achieved by regulating the weight ratio of the incorporated MgO and MgCO3 particles. Via controlled release of Mg2+, PMM hydrogels significantly promoted proliferation, osteogenic differentiation, migration, and biomineral deposition of immortalized mouse embryonic fibroblasts. More importantly, micro-CT imaging and histological analysis indicated that concomitant with their gradual degradation, PMM hydrogels effectively stimulated in situ bone regeneration in rat calvarial defects with an increase in the bone volume fraction of almost 2-fold compared with that in the control group. These findings suggest that injectable PMM hydrogels can satisfactorily match bone defects and form porous scaffolds in situ and can significantly promote bone regeneration via controllable Mg2+ release. The remarkable features of IPBHs may open a new avenue for the exploration of in situ repair systems for irregular bone defects to accelerate bone regeneration and have great potential for clinical translation.Keywords
Funding Information
- Natural Science Foundation of Chongqing Municipality (cstc2019jscxgksbX0027, cstc2020jcyj-msxm2234)
- China Postdoctoral Science Foundation (2021M693754)
- National Natural Science Foundation of China (82102909)
- the Top-notch Young Talent Project of the Chongqing Hospital of Traditional Chinese Medicine (CQSZYY2020008)
- Chongqing graduate research innovation project (CYS20199)
This publication has 48 references indexed in Scilit:
- Delivery of small molecules for bone regenerative engineering: preclinical studies and potential clinical applicationsDrug Discovery Today, 2014
- PLGA in situ implants formed by phase inversion: Critical physicochemical parameters to modulate drug releaseJournal of Controlled Release, 2013
- Cell–Material Interactions Revealed Via Material Techniques of Surface PatterningAdvanced Materials, 2013
- Conditionally Immortalized Mouse Embryonic Fibroblasts Retain Proliferative Activity without Compromising Multipotent Differentiation PotentialPLOS ONE, 2012
- Noninvasive Characterization of the Effect of Varying PLGA Molecular Weight Blends on In Situ Forming Implant Behavior Using Ultrasound ImagingTheranostics, 2012
- Bioceramics: From Bone Regeneration to Cancer NanomedicineAdvanced Materials, 2011
- In vitro and in vivo study of thymosin alpha1 biodegradable in situ forming poly(lactide-co-glycolide) implantsInternational Journal of Pharmaceutics, 2010
- Dual delivery of an angiogenic and an osteogenic growth factor for bone regeneration in a critical size defect modelBone, 2008
- Living with cracks: Damage and repair in human boneNature Materials, 2007
- Porous scaffold design for tissue engineeringNature Materials, 2005